217 related articles for article (PubMed ID: 33649518)
1. Transcriptional analysis of sodium valproate in a serotonergic cell line reveals gene regulation through both HDAC inhibition-dependent and independent mechanisms.
Sinha P; Cree SL; Miller AL; Pearson JF; Kennedy MA
Pharmacogenomics J; 2021 Jun; 21(3):359-375. PubMed ID: 33649518
[TBL] [Abstract][Full Text] [Related]
2. Valproic acid exposure leads to upregulation and increased promoter histone acetylation of sepiapterin reductase in a serotonergic cell line.
Balasubramanian D; Deng AX; Doudney K; Hampton MB; Kennedy MA
Neuropharmacology; 2015 Dec; 99():79-88. PubMed ID: 26151765
[TBL] [Abstract][Full Text] [Related]
3. The mood stabilizer valproate activates human FGF1 gene promoter through inhibiting HDAC and GSK-3 activities.
Kao CY; Hsu YC; Liu JW; Lee DC; Chung YF; Chiu IM
J Neurochem; 2013 Jul; 126(1):4-18. PubMed ID: 23647222
[TBL] [Abstract][Full Text] [Related]
4. Valproate recovers the inhibitory effect of dexamethasone on the proliferation of the adult dentate gyrus-derived neural precursor cells via GSK-3β and β-catenin pathway.
Boku S; Nakagawa S; Masuda T; Nishikawa H; Kato A; Takamura N; Omiya Y; Kitaichi Y; Inoue T; Kusumi I
Eur J Pharmacol; 2014 Jan; 723():425-30. PubMed ID: 24211784
[TBL] [Abstract][Full Text] [Related]
5. Gene expression effects of lithium and valproic acid in a serotonergic cell line.
Balasubramanian D; Pearson JF; Kennedy MA
Physiol Genomics; 2019 Feb; 51(2):43-50. PubMed ID: 30576260
[TBL] [Abstract][Full Text] [Related]
6. Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition.
Leng Y; Liang MH; Ren M; Marinova Z; Leeds P; Chuang DM
J Neurosci; 2008 Mar; 28(10):2576-88. PubMed ID: 18322101
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic evidence of an Ac/Dc axis by VPA and SAHA.
Lunke S; Maxwell S; Khurana I; K N H; Okabe J; Al-Hasani K; El-Osta A
Clin Epigenetics; 2021 Mar; 13(1):58. PubMed ID: 33743782
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylases are required for amphibian tail and limb regeneration but not development.
Taylor AJ; Beck CW
Mech Dev; 2012; 129(9-12):208-18. PubMed ID: 22947425
[TBL] [Abstract][Full Text] [Related]
9. Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons.
Hall AC; Brennan A; Goold RG; Cleverley K; Lucas FR; Gordon-Weeks PR; Salinas PC
Mol Cell Neurosci; 2002 Jun; 20(2):257-70. PubMed ID: 12093158
[TBL] [Abstract][Full Text] [Related]
10. FGF-21, a novel metabolic regulator, has a robust neuroprotective role and is markedly elevated in neurons by mood stabilizers.
Leng Y; Wang Z; Tsai LK; Leeds P; Fessler EB; Wang J; Chuang DM
Mol Psychiatry; 2015 Feb; 20(2):215-23. PubMed ID: 24468826
[TBL] [Abstract][Full Text] [Related]
11. The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons.
Yasuda S; Liang MH; Marinova Z; Yahyavi A; Chuang DM
Mol Psychiatry; 2009 Jan; 14(1):51-9. PubMed ID: 17925795
[TBL] [Abstract][Full Text] [Related]
12. Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity.
Leng Y; Chuang DM
J Neurosci; 2006 Jul; 26(28):7502-12. PubMed ID: 16837598
[TBL] [Abstract][Full Text] [Related]
13. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM
Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of TrkB Expression and Signaling by Valproic Acid and Other Histone Deacetylase Inhibitors.
Dedoni S; Marras L; Olianas MC; Ingianni A; Onali P
J Pharmacol Exp Ther; 2019 Sep; 370(3):490-503. PubMed ID: 31308194
[TBL] [Abstract][Full Text] [Related]
15. Neuroanatomical profile of antimaniac effects of histone deacetylases inhibitors.
Arent CO; Valvassori SS; Fries GR; Stertz L; Ferreira CL; Lopes-Borges J; Mariot E; Varela RB; Ornell F; Kapczinski F; Andersen ML; Quevedo J
Mol Neurobiol; 2011 Jun; 43(3):207-14. PubMed ID: 21424678
[TBL] [Abstract][Full Text] [Related]
16. Differential display PCR reveals novel targets for the mood-stabilizing drug valproate including the molecular chaperone GRP78.
Wang JF; Bown C; Young LT
Mol Pharmacol; 1999 Mar; 55(3):521-7. PubMed ID: 10051536
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen.
Phiel CJ; Zhang F; Huang EY; Guenther MG; Lazar MA; Klein PS
J Biol Chem; 2001 Sep; 276(39):36734-41. PubMed ID: 11473107
[TBL] [Abstract][Full Text] [Related]
18. Sodium valproate potentiates staurosporine-induced apoptosis in neuroblastoma cells via Akt/survivin independently of HDAC inhibition.
Shah RD; Jagtap JC; Mruthyunjaya S; Shelke GV; Pujari R; Das G; Shastry P
J Cell Biochem; 2013 Apr; 114(4):854-63. PubMed ID: 23097134
[TBL] [Abstract][Full Text] [Related]
19. Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors.
Cho HH; Park HT; Kim YJ; Bae YC; Suh KT; Jung JS
J Cell Biochem; 2005 Oct; 96(3):533-42. PubMed ID: 16088945
[TBL] [Abstract][Full Text] [Related]
20. A common mechanism of action for three mood-stabilizing drugs.
Williams RS; Cheng L; Mudge AW; Harwood AJ
Nature; 2002 May; 417(6886):292-5. PubMed ID: 12015604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
